2021 IPO

Ginkgo Bioworks Stock

Custom Microbes Design

Sign up today and learn more about Ginkgo Bioworks Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Y Combinator


Boston MA, US

Total Funding


About Ginkgo Bioworks Stock

Ginkgo Bioworks is a biotech company that designs custom microbes. The company creates custom microbes for three main areas: cultured ingredients, strain improvement, and enzymes. For cultured ingredients, Ginkgo Bioworks creates engineered yeasts to produce ingredients via fermentation for perfumes, foods, cosmetics, etc. For strain improvement, Ginkgo Bioworks engineers in-use organisms to improve efficiency and sustainability. For enzymes, Ginkgo Bioworks aims to discover "better" enzymes for various applications, such as cheesemaking and pharmaceuticals.

Ginkgo Bioworks' platform consists of its Foundries and Codebase. Foundries are Ginkgo Bioworks way to automate organism design and Codebase is Ginkgo Bioworks' library of cell, enzyme and genetic programs that help jumpstart new programs and discoveries.

Ginkgo Bioworks was founded in 2009. The company is based in Boston, Massachusetts.


Funding History

July 2015$20K
June 2016$37K
October 2017$109K
September 2019$232K


Chief Executive Officer

Jason Kelly


Barry Canton


Austin Che


Tom Knight


Reshma Shetty


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: